Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Making cancer immunotherapy a surer bet

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 552, S72-S73 (2017)


This article is part of Nature Outlook: Cancer immunotherapy, an editorially independent supplement produced with the financial support of third parties. About this content.


  1. Garon, E. B. et al. N. Engl. J. Med. 372, 2018–2028 (2015).

    Article  PubMed  Google Scholar 

  2. Le, D. T. et al. Science 357, 409–413 (2017).

    Article  PubMed  CAS  Google Scholar 

  3. Hugo, W. et al. Cell 165, 35–44 (2016).

    Article  PubMed  CAS  Google Scholar 

  4. Tumeh, P. C. et al. Nature 515, 568–571 (2014).

    Article  PubMed  CAS  Google Scholar 

  5. Chen, P. L. et al. Cancer Discov. 6, 827–837 (2016).

    Article  PubMed  CAS  Google Scholar 

  6. Huang, A. C. et al. Nature 545, 60–65 (2017).

    Article  PubMed  CAS  Google Scholar 

Download references


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links